A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)

Name: A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)
Published: 2020
License: Public Domain

Bayer · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

endometriosis related pain, overactive bladder, diabetic neuropathic pain, refractory or unexplained chronic cough, healthy volunteers, pharmacokinetics (pk), interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)

Related documents